Aclaris Therapeutics (NASDAQ:ACRS) outlined multiple clinical and near-term development milestones across its large-molecule and small-molecule pipeline during a presentation at the Leerink Partners ...

Add Yahoo as a preferred source to see more of our stories on Google. With Gen Z street cred on one hand and brand-building prowess on the other, Maesa has teamed up with creators Brooklyn and Bailey ...

T regulatory (Treg) cells promote immune tolerance and suppress inflammation 1,2. Unlike Treg cells that stably express the transcription factor Foxp3, type 1 regulatory T (Tr1) cells have no or ...

The last time I spoke about Corvus Pharmaceuticals, Inc. (CRVS), it was in a Seeking Alpha article entitled "Corvus Pharmaceuticals: Positive Phase 1 Soquelitinib Trial Data Brings 2025 Catalysts." ...

In its original avatar, ITK trained specialised coaches exclusively for the German set-up that made it a world power before the unification in the late '60s and early '70s. Germany's unprecedented ...